Microbot Medical (MBOT) Competitors

Microbot Medical logo
$1.99 -0.17 (-7.87%)
Closing price 02/14/2025 04:00 PM Eastern
Extended Trading
$2.00 +0.01 (+0.25%)
As of 02/14/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MBOT vs. PROF, INFU, TLSI, ZJYL, SGHT, LNSR, HYPR, STIM, ECOR, and PDEX

Should you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Profound Medical (PROF), InfuSystem (INFU), TriSalus Life Sciences (TLSI), Jin Medical International (ZJYL), Sight Sciences (SGHT), LENSAR (LNSR), Hyperfine (HYPR), Neuronetics (STIM), electroCore (ECOR), and Pro-Dex (PDEX). These companies are all part of the "medical equipment" industry.

Microbot Medical vs.

Profound Medical (NASDAQ:PROF) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment, valuation and community ranking.

In the previous week, Microbot Medical had 4 more articles in the media than Profound Medical. MarketBeat recorded 8 mentions for Microbot Medical and 4 mentions for Profound Medical. Microbot Medical's average media sentiment score of 0.30 beat Profound Medical's score of -0.15 indicating that Microbot Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Profound Medical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Microbot Medical
2 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

47.9% of Profound Medical shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 1.5% of Profound Medical shares are held by company insiders. Comparatively, 10.5% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Microbot Medical has lower revenue, but higher earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Profound Medical$7.20M27.95-$28.57M-$1.34-5.00
Microbot MedicalN/AN/A-$10.74M-$0.80-2.49

Profound Medical has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500.

Profound Medical presently has a consensus price target of $14.25, indicating a potential upside of 112.69%. Microbot Medical has a consensus price target of $9.00, indicating a potential upside of 352.26%. Given Microbot Medical's higher possible upside, analysts plainly believe Microbot Medical is more favorable than Profound Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Profound Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
Microbot Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Microbot Medical received 308 more outperform votes than Profound Medical when rated by MarketBeat users. However, 72.73% of users gave Profound Medical an outperform vote while only 70.73% of users gave Microbot Medical an outperform vote.

CompanyUnderperformOutperform
Profound MedicalOutperform Votes
40
72.73%
Underperform Votes
15
27.27%
Microbot MedicalOutperform Votes
348
70.73%
Underperform Votes
144
29.27%

Microbot Medical has a net margin of 0.00% compared to Profound Medical's net margin of -349.41%. Profound Medical's return on equity of -85.22% beat Microbot Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Profound Medical-349.41% -85.22% -64.87%
Microbot Medical N/A -218.30%-158.17%

Summary

Microbot Medical beats Profound Medical on 10 of the 18 factors compared between the two stocks.

Get Microbot Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBOT vs. The Competition

MetricMicrobot MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$43.92M$4.80B$5.85B$9.14B
Dividend YieldN/A51.43%5.27%4.00%
P/E Ratio-2.4925.6026.1519.39
Price / SalesN/A60.52470.8677.82
Price / CashN/A50.3946.1438.90
Price / Book5.246.557.275.05
Net Income-$10.74M$89.44M$3.19B$222.74M
7 Day Performance-21.96%1.45%2.81%2.11%
1 Month Performance11.17%2.34%4.59%2.33%
1 Year Performance54.26%18.62%22.58%16.80%

Microbot Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBOT
Microbot Medical
2.4788 of 5 stars
$1.99
-7.9%
$9.00
+352.3%
+64.5%$43.92MN/A-2.4920Short Interest ↑
Gap Down
PROF
Profound Medical
2.8027 of 5 stars
$5.85
-2.6%
$14.25
+143.8%
-21.2%$175.58M$7.20M-4.36150News Coverage
INFU
InfuSystem
2.4823 of 5 stars
$8.11
+3.7%
$13.00
+60.3%
N/A$172.42M$125.79M135.19410
TLSI
TriSalus Life Sciences
3.9628 of 5 stars
$5.59
+0.3%
$11.79
+111.0%
-42.3%$170.29M$18.51M-2.24106Analyst Forecast
ZJYL
Jin Medical International
N/A$1.01
+22.2%
N/A-89.5%$157.33M$23.50M0.00245Gap Down
SGHT
Sight Sciences
3.5965 of 5 stars
$2.68
-3.4%
$4.68
+75.1%
-36.0%$135.78M$81.06M-2.62210News Coverage
LNSR
LENSAR
1.0256 of 5 stars
$11.22
+2.3%
$8.00
-28.7%
+123.4%$130.26M$42.16M-7.68110Positive News
Gap Up
HYPR
Hyperfine
2.11 of 5 stars
$1.66
+2.2%
$1.60
-3.3%
+12.1%$120.73M$11.03M-2.90190High Trading Volume
STIM
Neuronetics
0.9129 of 5 stars
$3.86
+25.7%
$4.67
+20.9%
+25.3%$117.12M$71.35M-3.14180Insider Trade
News Coverage
Gap Up
High Trading Volume
ECOR
electroCore
2.5028 of 5 stars
$17.08
+3.0%
$25.00
+46.4%
+141.8%$113.75M$16.03M-9.3350Short Interest ↑
PDEX
Pro-Dex
3.7865 of 5 stars
$33.32
-0.8%
$52.00
+56.0%
+96.9%$108.67M$61.00M16.58140

Related Companies and Tools


This page (NASDAQ:MBOT) was last updated on 2/15/2025 by MarketBeat.com Staff
From Our Partners